[HTML][HTML] Long non-coding RNAs and exosomal lncRNAs: Potential functions in lung cancer progression, drug resistance and tumor microenvironment remodeling

M Entezari, M Ghanbarirad, A Taheriazam… - Biomedicine & …, 2022 - Elsevier
Among the different kinds of tumors threatening human life, lung cancer is one that is
commonly observed in both males and females. The aggressive behavior of lung cancer …

Noncoding RNAs in extracellular fluids as cancer biomarkers: the new frontier of liquid biopsies

B Pardini, AA Sabo, G Birolo, GA Calin - Cancers, 2019 - mdpi.com
The last two decades of cancer research have been devoted in two directions:(1)
understanding the mechanism of carcinogenesis for an effective treatment, and (2) …

The function of LncRNAs and their role in the prediction, diagnosis, and prognosis of lung cancer

Y Chen, E Zitello, R Guo, Y Deng - Clinical and translational …, 2021 - Wiley Online Library
Lung cancer remains a major threat to human health. Low dose CT scan (LDCT) has
become the main method of early screening for lung cancer due to the low sensitivity of …

Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer

C Liu, X Xiang, S Han, HY Lim, L Li, X Zhang, Z Ma… - Cancer Letters, 2022 - Elsevier
Currently, early detection of lung cancer relies on the characterisation of images generated
from computed tomography (CT). However, lung tissue biopsy, a highly invasive surgical …

Exosomal ncRNAs in liquid biopsies for lung cancer

MS Hussain, G Gupta, N Ghaboura, E Moglad… - Clinica chimica acta, 2024 - Elsevier
Exosomal non-coding RNAs (ncRNAs) have become essential contributors to advancing
and treating lung cancers (LCs). The development of liquid biopsies that utilize exosomal …

[HTML][HTML] New insights into long non-coding RNAs in non-small cell lung cancer

R Ye, R Tang, S Gan, R Li, Y Cheng, L Guo… - Biomedicine & …, 2020 - Elsevier
Lung cancer is a malignant tumor that seriously threatens human life and health. Non-small
cell lung cancer (NSCLC) accounts for 85% of all lung cancer cases, and its global 5-year …

[HTML][HTML] Puzzling out the role of MIAT LncRNA in hepatocellular carcinoma

RA Elmasri, AA Rashwan, SH Gaber… - Non-coding RNA …, 2024 - Elsevier
A non-negligible part of our DNA has been proven to be transcribed into non-protein coding
RNA and its intricate involvement in several physiological processes has been highly …

LncRNA‐AK137033 inhibits the osteogenic potential of adipose‐derived stem cells in diabetic osteoporosis by regulating Wnt signaling pathway via DNA methylation

S Peng, Y Gao, S Shi, D Zhao, H Cao, T Fu… - Cell …, 2022 - Wiley Online Library
Objectives Bone tissue engineering based on adipose‐derived stem cells (ASCs) is
expected to become a new treatment for diabetic osteoporosis (DOP) patients with bone …

Liquid biopsy for therapy monitoring in early-stage non-small cell lung cancer

M Nagasaka, MH Uddin, MN Al-Hallak, S Rahman… - Molecular Cancer, 2021 - Springer
Liquid biopsy is now considered a valuable diagnostic tool for advanced metastatic non-
small cell lung cancer (NSCLC). In NSCLC, circulating tumor DNA (ctDNA) analysis has …

LncRNA GAS5 regulated by FTO-mediated m6A demethylation promotes autophagic cell death in NSCLC by targeting UPF1/BRD4 axis

Y Fu, L Liu, H Wu, Y Zheng, H Zhan, L Li - Molecular and Cellular …, 2024 - Springer
Long non-coding RNA (lncRNA) growth arrest-specific transcript 5 (GAS5) has been shown
to be a regulator for many cancers, including non-small cell lung cancer (NSCLC) …